Europe

Dec 10, 2017
Pharmaceutical Executive
New action plan urges tighter alignment of public health policy with the development of targeted therapies.
Nov 17, 2017
Allergan's CEO Brent Saunders explains why the European Medicines Agency should choose Dublin as its headquarters after leaving London.
Oct 10, 2017
Pharmaceutical Executive
European Commission talks drug industry investment, health issues during State of the Union.
Oct 06, 2017
The UK's Association of the British Pharmaceutical Industry had hoped to stop a new policy that amounts to price negotiation and potentially delaying access to new medicines.
Sep 28, 2017
Leela Barham looks at the reasons behind the Association of the British Pharmaceutical Industry's bid to legally challenge NICE's proposed introduction of the budget impact test.
Sep 05, 2017
Reflector asks if the UK's newly announced post-Brexit life sciences strategy report is worth a look as a springboard to addressing future EU ties in healthcare, or just more bluster?
Sep 04, 2017
Leela Barham casts her eye over the UK's plans for its life sciences industry in the post-Brexit world.
Aug 29, 2017
With a new consultation from the UK’s Department of Health proposing changes to the Statutory Scheme for Pricing of Branded Medicines, what could this mean for negotiation of a successor to the Pharmaceutical Price Regulation Scheme? Leela Barham reports.
Aug 07, 2017
Pharmaceutical Executive
A review of the top contenders to land the agency as decision on its relocation draws closer.
Jul 28, 2017
The UK is entering into unchartered waters between Brexit – offering potentially new approaches to procurement – and negotiating a successor to the PPRS. The government's new recruit Steve Oldfield could give it the inside track, writes Leela Barham.
native1_300x100
lorem ipsum